Slone Partners works closely with Codexis to place MDx expert after nationwide search
March 7, 2018, San Francisco, CA — Slone Partners, North America’s preeminent healthcare executive search firm, proudly announces the successful placement of Ms. Shawn Clairmont in the newly-created position of Senior Director of Molecular Diagnostics at Codexis Inc. (NASDAQ: CDXS), a leading protein engineering company. With an exceptional 13 years molecular diagnostics strategic marketing experience, Ms. Clairmont proved uniquely suited to shepherd Codexis’ first commercialization of high-performance enzymes for use in next generation sequencing and polymerase chain reaction (PCR/qPCR) applications. Slone Partners, working closely with Codexis Senior VP Corporate & Strategic Development Michael Aldridge, conducted a nationwide search.
Ms. Clairmont will be responsible for all commercial activities related to the molecular diagnostics enzyme product line, including product launches and market and pricing strategies, based at Codexis corporate headquarters in Redwood City, California. Ms. Clairmont, who holds an MBA from the College of Saint Scholastica in Duluth, MN and a BA in biology from Saint Olaf College in Northfield, MN, most recently served as COO of BRIDGenomics, a molecular diagnostics and medical device marketing consultancy. Prior, she served as Director of Sales, America on the Global Advanced Molecular Pathology Team at QIAGEN.
Says Kochis-Stach, “Slone Partners values our ongoing search relationship with Codexis, which is exemplified by the appointment of well-respected veteran Shawn Clairmont in this vital new role. She’s poised to do a wonderful job bringing new enzymes and protein engineering platforms like CodeEvolver® to the global marketplace.”